A Phase I/II Study of AMG 510 in Combination with MVASI in Patients with Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC with Asymptomatic Brain Metastasis

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

University of Colorado Hospital

Principal Investigator
Photograph of David Camidge,  MD, PhD

David Camidge, MD, PhD

Study ID

Protocol Number: 22-0099

More information available at ClinicalTrials.gov: NCT05180422

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers